
Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.
CMS will not appeal preliminary injunction against average manufacturer price rule.
The Centers for Medicare & Medicaid Services has decided not to appeal a preliminary injunction that has blocked it from implementing the






